Markets

  1. Home
Market Nav

LUPIN LTD.

  • NSE CodeLUPINEQ
  • BSE Code500257
  • ISININE326A01037
  • IndustryPharmaceuticals

Company Information

Management

Manju D Gupta

Chairman

Incorporation Year

01/03/1983

Registered Address

Registered Office : Kalpataru Inspire, 3rd Floor, , Off. Western Express Highway, , Santacruz (East),
Mumbai, Maharashtra - 400055
Tel: 022-66402323

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

info@lupin.com

Website

http://www.lupin.com

Listing

BSE, BSE, MCXSX, NSE

Corporate News

Lupin launches Generic Tolvaptan in US with 180-Day e...

13-May-2025|1:05PM

Lupin Ltd announced on Tuesday the launch of its generic version of Tolvapt

Lupin Ltd. - Announcement under Regulation 30 (LODR)-...

13-May-2025|11:54AM

Lupin Launches Tolvaptan Tablets in the U.S. with 180-Day Exclusivity.

Lupin Ltd. - Press Release

08-May-2025|3:39PM

Lupin Limited has informed the Exchange regarding a press release dated May

Lupin Ltd. - Announcement under Regulation 30 (LODR)-...

08-May-2025|3:37PM

Lupin Receives Approval from U.S. FDA for Raltegravir Tablets USP, 600 mg.

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug54.25153.82
Aarti Drug453.504,139.09
Aarti Pharma780.557,074.49
Abbott India30,390.0064,576.63
Accent Micro211.30444.64
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
HDFC Ba..1141.851.20
HDFC La..683.221.89
Mirae A..641.111.70
Axis Mi..606.922.14
ICICI P..572.571.17
More

Board Meetings

DatePurpose
14/05/2025Audited Results & F..
11/02/2025Quarterly Results &..
07/11/2024Quarterly Results
06/08/2024Quarterly Results
06/05/2024Audited Results & F..
More